Health Law Policy

  • Read more: Twitter Round-Up 1/1-1/13
    Article

    Twitter Round-Up 1/1-1/13

    By Casey Thomson Due to the string of December holidays and some traveling by the round-up author, this post belatedly summarizes tweets from the end of 2012 to the beginning days of the new year. The round-up will resume a regular schedule following the conclusion of this week. Read below for this (extended) round-up: Frank…

  • Read more: Tomorrow! Food & Drug Law: Past, Present & Future
    Article

    Tomorrow! Food & Drug Law: Past, Present & Future

    Food & Drug Law: Past, Present & Future Celebrating Peter Barton Hutt’s 20 Years (thus far) at HLS Thursday, January 17, 2013 Wasserstein 2019; Milstein West AB Harvard Law School 4:00pm (reception to follow) Peter Barton Hutt has worked at the Washington, DC law firm of Covington & Burling, specializing in Food and Drug Law, for…

  • Read more: Tell Patients: It’s Not All About YOU
    Article

    Tell Patients: It’s Not All About YOU

    By Art Caplan [cross-posted on MedScape] This flu season is proving to be a doozy. The Centers for Disease Control and Prevention (CDC) in Atlanta say that this is one of the worst flu seasons ever. The agency reported severe flu cases in 46 states during the last week of December 2012. Eighteen states are…

  • Read more: Guest Post on Animal Research: Animal Research Is an Ethical and Vital Tool to Fight Disease
    Article

    Guest Post on Animal Research: Animal Research Is an Ethical and Vital Tool to Fight Disease

    By Tom Holder [Ed. Note: A few weeks ago, we had a post comparing the protections offered to humans and animals used in research, and it prompted quite a stir.  We thought the issues merited more discussion from both sides, and therefore solicited blog posts from two divergent perspectives: Theodora Capaldo, President of the New England Anti-Vivisection Society and Tom Holder,…

  • Read more: Guest Post on Animal Research: Inadequate laws don’t – but research alternatives will – protect animals in labs
    Article

    Guest Post on Animal Research: Inadequate laws don’t – but research alternatives will – protect animals in labs

    By Theodora Capaldo [Ed. Note: A few weeks ago, we had a post comparing the protections offered to humans and animals used in research, and it prompted quite a stir. We thought the issues merited more discussion from both sides, and therefore solicited blog posts from two divergent perspectives: Theodora Capaldo, President of the New…

  • Read more: Where Are We Now: Post 5, Ways of Being Wrong – and Opportunities to be Right
    Article

    Where Are We Now: Post 5, Ways of Being Wrong – and Opportunities to be Right

    By Scott Burris The main contests (a summary of previous posts): A lot of people in public health practice seem to be (appropriately) concerned about our public health infrastructure – the agencies within public health systems where day to day work is done. Public health infrastructure tends to get taken for granted and neglected. Core…

  • Read more: Maintenance of Effort in Maine
    Article

    Maintenance of Effort in Maine

    By Kevin Outterson After the NFIB decision in June, Maine tried to expand Justice Roberts’ remedy to also make the “maintenance of effort” provision optional for states. Maine was unsuccessful in the First Circuit with the argument, for procedural reasons.  Prior coverage here. The Obama Administration is sticking to the letter of the law, and announced Tuesday that it…

  • Read more: At $28,000 a Dose, How Effective Is Acthar?
    Article

    At $28,000 a Dose, How Effective Is Acthar?

    By Jonathan J. Darrow In a well-researched, recent post, Patrick O’Leary addresses the FDA’s efficacy requirements as applied to an old drug, Acthar (corticotropin), that was first approved in 1952 and granted an orphan designation in 2010 for the treatment of infantile spasms. The initial approval therefore occurred before the Drug Amendments of 1962, which…